Published in Medicine and Law Weekly, September 16th, 2005
BioLife president and CEO John G. Baust, PhD, said that the market for preserving cells and tissue is growing rapidly and is diverging into new technology areas, one of which is vitrification or freezing rapidly to avoid the presence of ice crystals.
Baust said, "Our core preservation technologies can be a critical factor in applying this new technology and solidifying our patent position in that area gives us a commercial foothold as that market develops."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.